Reports of a respiratory disease called human metapneumovirus (hMPV) spreading in China have stoked fears and misinformation on social media. Some posts claimed that this is a new virus and that ...

Several cases of HMPV have also been reported in many Asian countries such as Hong Kong and India. ALSO READ: Kanye West shocking escape: Why is the rapper 'terrified' and planning to stay away ...

Human metapneumovirus (HMPV) is another in the catalog of respiratory viruses causing a stir. The virus peaked in spring, affecting a number of children and the elderly, per CNN. Most of the time ...

Human metapneumovirus (HMPV), although discovered in 2001, is making headlines after an unspecified increase in cases was reported in China. Although it has not been officially pronounced by local ...

First reported in children from the Netherlands in 2001. Retrospective studies have shown the presence of human metapneumovirus (HMPV) in the human population from as early as the 1950s.

People in the UK have been advised to avoid some medical settings and to wear masks in some hospitals and clinics after a rise in cases of a virus now as HMPV. Infections caused concern when there ...

Cases of human metapneumovirus (hMPV) are rising in the UK, weeks after images of packed hospital waiting rooms in China sparked alarm on social media. It was dubbed the “mystery virus” as ...

(Background image: People wearing protective face masks as a preventive measure against the spread of HMPV in India/Right image: Prof Sarath Ranganathan, a Melbourne-based expert in respiratory ...

Human Metapneumovirus (HMPV) causes respiratory infections, mainly affecting young children and the elderly. It is spread through respiratory droplets and can lead to severe complications.

The HMPV is a respiratory virus that can cause mild to severe illness. The vulnerable group includes young children, older adults, and individuals with weakened immune systems A one-year-old girl ...

The incubation period for HMPV is usually between three and six days, with symptoms lasting for varying durations depending on the severity of the infection ...

hVIVO plc (AIM: HVO), a fast-growing early-stage Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces that, following the success of its pilot human ...